Afinitor®, the Novartis trademark for the cancer fighter, everolimus, is used for the treatment of advanced renal cell carcinoma (RCC), inoperable cases of certain pancreatic cancers, and to aid successful acceptance of transplants. Now, the results of a Phase III study of Afinitor administered to women with advanced breast cancer have been announced, and the words used to describe the drug are "game changer."
In the next logical step for internal hard disk drives, industry giant Seagate is planning to introduce a new drive capable of holding 4000 gigabytes of data, in a traditional 3.5” size for easy installation into most desktop computers.
There is nothing more discouraging in human discourse than someone yawning in your face while you're speaking to him. "Oh, excuse me," he might say, "I guess I'm just very tired." (Yeah, sure!)
But now, scientists have evidence that your listener may not be bored at all; but just chilling... his brain.
Arthritis is a joint disease that results in a progressive loss of cartilage, just as osteoporosis results in progressive loss of bone. Though osteoporosis drugs are intended to regenerate bone growth, to date, arthritis drugs can only reduce inflammation and, thereby, reduce pain. But observation of patients taking a certain osteoporosis drug, by researchers at the University of Rochester Medical Center (URMC), led to the recent finding that this drug not only restored bone but cartilage as well.
In what is believed to be the first instance of electronic gamers reaching a scientific discovery before trained research scientists, University of Washington (UW) gamers did indeed produce a model of an enzyme in AIDS and other viruses that scientists have been trying to model for more than 10 years. This was not just an academic exercise to test the new UW Fold-it game; discovery of the AIDS molecule in question opens the door to a whole new line of retroviral drugs.
Learning to walk again after breaking a leg or hip, having a stroke, prosthetic, or partial paralysis depends on a lot of persistence and an excellent rehabilitation program that can guide you through gait training. Movement scientist Dr. Melvyn Roerdink from The Netherlands has developed a super smart, oversized treadmill that helps rehab patients gain confidence in their new gaits, with bells, whistles, and even light shows.
The U.S. Department of Agriculture (USDA) revamped its healthy eating recommendations a few months ago with a new visual - an icon called 'MyPlate,' replacing the former healthy foods pyramid icon. The Nutrition Source at the Harvard School of Public Health thinks the government's plate lacks a good bit of guidance as to which specific foods should be eaten - after all MyPlate offers no guidance.
For many of the 13 million Americans currently at risk for non-melanoma skin cancers, the VivoSight® Optical Coherence Tomography (OCT) scanner will be a blessing in their dermatologists' tool closet. The device, just approved for clinical use by the FDA, offers real-time laser imaging of a patient's skin, enabling better, and sometimes immediate, treatment of basal or squamous cell cancers.
They keep making 'em bigger and bigger. Hitachi GST's latest lines of hard disks use ultra-dense platters that can hold 1TB apiece, allowing promising future developments for media gurus and digital packrats everywhere.
Scientists at the University of Southern California (USC) and the Mayo Clinic College of Medicine just achieved a scientific breakthrough that has the potential to revolutionize the design of neurological drugs: they captured the first high resolution images of the acetylcholine receptor (AChR), the α7 molecule responsible for transmitting signals between neurons, particularly those associated with learning and memory.
For the third year in a row, the Biomimicry Institute, a non-profit organication that promotes the study and imitation of designs found in nature, is sponsoring the Biomimicry Student Design Challenge. This year the Challenge, which is open to college students world-wide, is to use biomimicry to design a solution that results in more efficient use of energy and ultimately reduces greenhouse gases. No small feat, but the Institute provides students with plenty of resources on biomimicry....
Experiments with acne-piercing lasers have been conducted before, but this time, the laser electron is not "the size of an entire hospital," but the size of a DVD player. The unique laser system, the Raman Fiber Laser, has the potential to permanently alter sebaceous glands, those that give rise to pimples and acne, the bane of adolescence.
PC audio giant Creative Labs has announced a brand new audio processor, dubbed the Core3D, with a whopping four processing cores and a highly integrated design to lower sound card complexity.
It's so great to find innovations for disabled people on design websites, rather than buried in disability association files. "Design" says the world is paying attention to disability needs, and it cares that the latest technologies are employed in the tools and that they look pretty cool too. The Finger Reader is at least the second design for blind and visually impaired persons by Hansub Lee and it's a great accessibility creation for finding exactly what you want while shopping.
Until recently, one could rarely find a dog toy made of natural organic materials outside of a high-end specialty pet boutique. High end usually meant high prices, although many environmentally-conscious were willing to pay them. But it's common now to find dog toys mass marketed with both their stuffing and the adorable, colorful character patterns in totally organic materials... and they're much more affordable.
Historically, surgical removal or oral and throat cancers have not allowed patients to go back to living their normal daily lives. Oral cancer removals caused severe pain, particularly ugly scarring, and an inability to eat, speak, or swallow normally. Even breathing problems might result. But now along comes TORS, the robot with the right stuff.
Canadian researchers have made cancer treatment history with the success of an intravenous infusion of a virus, JX-594. The virus was injected into 23 patients with advanced and metastasized cancers who had not responded to traditional therapies. Not only was this the first test of viral therapy on human cancer patients, but the first trial to introduce a targeted virus intravenously.